Blinatumomab/MethotrexateGrade3/4 neurotoxicity and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2027卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67287-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：98 / 98

相关论文

共 50 条

[41] NivolumabDiarrhoea and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2051 (1) : 252 - 252
[42] WarfarinBleeding and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 480 - 480
[43] CamrelizumabHypothyroidism and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1970 (1) : 82 - 82
[44] AntiarrhythmicsDiarrhoea and lack of efficacy: 2 case reports
Reactions Weekly, 2020, 1808 (1) : 41 - 41
[45] BrivaracetamDrowsiness and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2032 (1) : 98 - 98
[46] NivolumabDermatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2039 (1) : 441 - 441
[47] EverolimusStomatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1934 (1) : 193 - 193
[48] ImatinibMyalgia and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1952 (1) : 186 - 186
[49] DapsoneMethaemoglobinaemia and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1901 (1) : 194 - 194
[50] MethotrexateLeukoencephalopathies and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2040 (1) : 567 - 567

← 1 2 3 4 5 →